Loading company…
Prothya Biosolutions makes plasma-derived medicinal products for immunology and critical care.
Prothya Biosolutions isolates and purifies proteins from human blood plasma to produce medicines such as immunoglobulins and clotting factors. The company supplies healthcare organizations and serves patients with critical care and immunology needs. Established in 2021 and based in Brussels, Belgium, it agreed to be acquired by Accord Healthcare Limited in August 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in